title: Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer.
abstract: An important mechanism by which pancreatic cancer avoids antitumor immunity is by recruiting regulatory T cells (Tregs) to the tumor microenvironment. Recent studies suggest that suppressor Tregs and effector Th17 cells share a common lineage and differentiate based on the presence of certain cytokines in the microenvironment. Because IL-6 in the presence of TGF-β has been shown to inhibit Treg development and induce Th17 cells, we hypothesized that altering the tumor cytokine environment could induce Th17 and reverse tumor-associated immune suppression. Pan02 murine pancreatic tumor cells that secrete TGF-β were transduced with the gene encoding IL-6. C57BL/6 mice were injected s.c. with wild-type (WT), empty vector (EV), or IL-6-transduced Pan02 cells (IL-6 Pan02) to investigate the impact of IL-6 secretion in the tumor microenvironment. Mice bearing IL-6 Pan02 tumors demonstrated significant delay in tumor growth and better overall median survival compared with mice bearing WT or EV Pan02 tumors. Immunohistochemical analysis demonstrated an increase in Th17 cells (CD4(+)IL-23R(+) cells and CD4(+)IL-17(+) cells) in tumors of the IL-6 Pan02 group compared with WT or EV Pan02 tumors. The upregulation of IL-17-secreting CD4(+) tumor-infiltrating lymphocytes was substantiated at the cellular level by flow cytometry and ELISPOT assay and mRNA level for retinoic acid-related orphan receptor γt and IL-23R by RT-PCR. Thus, the addition of IL-6 to the tumor microenvironment skews the balance toward Th17 cells in a murine model of pancreatic cancer. The delayed tumor growth and improved survival suggests that induction of Th17 in the tumor microenvironment produces an antitumor effect.
authors.affiliation: Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Gnerlich
authors.forename: Jonathan B
authors.initials: JB
authors.lastname: Mitchem
authors.forename: Joshua S
authors.initials: JS
authors.lastname: Weir
authors.forename: Narendra V
authors.initials: NV
authors.lastname: Sankpal
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kashiwagi
authors.forename: Brian A
authors.initials: BA
authors.lastname: Belt
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Porembka
authors.forename: John M
authors.initials: JM
authors.lastname: Herndon
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Eberlein
authors.forename: Peter
authors.initials: P
authors.lastname: Goedegebuure
authors.forename: David C
authors.initials: DC
authors.lastname: Linehan
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D045744:Cell Line, Tumor; D002469:Cell Separation; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D020381:Interleukin-17 / Q000096:biosynthesis / Q000276:immunology*; D015850:Interleukin-6 / Q000276:immunology / Q000378:metabolism; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D010190:Pancreatic Neoplasms / Q000276:immunology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism; D014161:Transduction, Genetic
chemical_list: D020381:Interleukin-17; D015850:Interleukin-6
references.citation: Int Immunol. 1998 Dec;10(12):1969-80
references.pmid: 9885918
references.citation: Clin Cancer Res. 2008 Jun 1;14(11):3254-61
references.pmid: 18519750
references.citation: J Exp Med. 2001 Sep 17;194(6):823-32
references.pmid: 11560997
references.citation: Nat Med. 2004 Sep;10(9):942-9
references.pmid: 15322536
references.citation: Clin Cancer Res. 2001 Mar;7(3 Suppl):925s-932s
references.pmid: 11300493
references.citation: J Immunol. 2008 Sep 1;181(5):3137-47
references.pmid: 18713984
references.citation: Ann Surg Oncol. 2006 Sep;13(9):1252-8
references.pmid: 16952047
references.citation: Clin Cancer Res. 2006 Sep 15;12(18):5423-34
references.pmid: 17000676
references.citation: Nature. 2006 May 11;441(7090):235-8
references.pmid: 16648838
references.citation: Immunity. 2006 Feb;24(2):179-89
references.pmid: 16473830
references.citation: J Leukoc Biol. 2002 Jan;71(1):1-8
references.pmid: 11781375
references.citation: Int Immunol. 2004 Aug;16(8):1203-13
references.pmid: 15237111
references.citation: J Immunol. 2007 Jun 1;178(11):6730-3
references.pmid: 17513719
references.citation: J Immunol. 2006 Jun 15;176(12):7768-74
references.pmid: 16751425
references.citation: J Immunol. 2008 Nov 1;181(9):5948-55
references.pmid: 18941183
references.citation: J Immunol. 1999 Nov 15;163(10):5211-8
references.pmid: 10553041
references.citation: Cancer Res. 1992 Nov 1;52(21):6020-4
references.pmid: 1394227
references.citation: Cancer Res. 1999 Aug 1;59(15):3698-704
references.pmid: 10446984
references.citation: Blood. 2009 Jun 11;113(24):6102-11
references.pmid: 19366986
references.citation: J Biol Chem. 2007 Mar 30;282(13):9358-9363
references.pmid: 17277312
references.citation: Nat Immunol. 2005 Nov;6(11):1133-41
references.pmid: 16200068
references.citation: Pancreas. 2006 Nov;33(4):386-90
references.pmid: 17079944
references.citation: Immunity. 2008 Jul 18;29(1):44-56
references.pmid: 18585065
references.citation: Blood. 2003 Apr 1;101(7):2620-7
references.pmid: 12411307
references.citation: J Exp Med. 2005 Jan 17;201(2):233-40
references.pmid: 15657292
references.citation: Nat Immunol. 2007 Sep;8(9):967-74
references.pmid: 17581537
references.citation: Cancer Res. 2001 Jun 15;61(12):4766-72
references.pmid: 11406550
references.citation: J Exp Med. 2001 Jun 4;193(11):F41-6
references.pmid: 11390442
references.citation: J Immunol. 2006 Nov 15;177(10):7398-405
references.pmid: 17082659
references.citation: Biochem Biophys Res Commun. 2008 Sep 26;374(3):533-7
references.pmid: 18655770
references.citation: Nat Rev Cancer. 2005 Apr;5(4):263-74
references.pmid: 15776005
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15505-10
references.pmid: 18832156
references.citation: J Immunol. 1992 Apr 15;148(8):2622-9
references.pmid: 1348521
references.citation: Annu Rev Immunol. 2007;25:821-52
references.pmid: 17201677
references.citation: Cytokine Growth Factor Rev. 2003 Apr;14(2):155-74
references.pmid: 12651226
references.citation: J Exp Med. 2003 Dec 15;198(12):1951-7
references.pmid: 14662908
references.citation: Cancer Res. 2007 Dec 15;67(24):11970-9
references.pmid: 18089828
references.citation: Immunity. 2008 Jan;28(1):29-39
references.pmid: 18164222
references.citation: Nature. 2006 May 11;441(7090):231-4
references.pmid: 16648837
references.citation: Cancer Res. 1992 Jul 1;52(13):3679-86
references.pmid: 1617640
references.citation: J Immunol. 2005 Nov 1;175(9):6177-89
references.pmid: 16237115
references.citation: Clin Cancer Res. 2008 Nov 1;14(21):6770-9
references.pmid: 18980970
references.citation: Blood. 2008 Jul 15;112(2):362-73
references.pmid: 18354038
references.citation: Immunity. 2004 Oct;21(4):467-76
references.pmid: 15485625
references.citation: Nat Immunol. 2007 Apr;8(4):345-50
references.pmid: 17375096
references.citation: J Immunol. 2004 Dec 1;173(11):6526-31
references.pmid: 15557141
references.citation: J Exp Med. 2005 Apr 4;201(7):1061-7
references.pmid: 15809351
references.citation: J Exp Med. 2003 Dec 15;198(12):1875-86
references.pmid: 14676299
references.citation: Int Immunol. 2004 Sep;16(9):1241-9
references.pmid: 15249539
references.citation: J Immunother. 2009 Jan;32(1):12-21
references.pmid: 19307989
references.citation: J Exp Med. 2001 Aug 20;194(4):519-27
references.pmid: 11514607
references.citation: J Immunol. 2003 Dec 1;171(11):6173-7
references.pmid: 14634133
references.citation: J Immunol. 2002 Sep 1;169(5):2756-61
references.pmid: 12193750
references.citation: Blood. 2002 Mar 15;99(6):2114-21
references.pmid: 11877287
references.citation: Immunol Res. 2005;32(1-3):155-68
references.pmid: 16106066
references.citation: Cancer Res. 1984 Feb;44(2):717-26
references.pmid: 6692374
references.citation: J Exp Med. 1996 Jun 1;183(6):2593-603
references.pmid: 8676080
references.citation: J Immunother. 2006 Jul-Aug;29(4):416-24
references.pmid: 16799337
references.citation: Nature. 2007 Jul 26;448(7152):480-3
references.pmid: 17581589
references.citation: Nat Immunol. 2005 Nov;6(11):1123-32
references.pmid: 16200070
references.citation: Cell. 2006 Sep 22;126(6):1121-33
references.pmid: 16990136